Sequential intravesical gemcitabine/docetaxel provides a durable remission in recurrent high-risk NMIBC following BCG therapyKendrick Yim, Mark A. Preston, Sarah L. Mott et al.|Urologic Oncology Seminars and Original Investigations|2023Cited by 31